ID   CNTRL_HUMAN             Reviewed;        2325 AA.
AC   Q7Z7A1; A2A2Y1; B2RP67; Q3MN79; Q5FWF8; Q5JVD0; Q6MZR3; Q6PKC1; Q8TEP3;
AC   Q9Y489;
DT   18-MAR-2008, integrated into UniProtKB/Swiss-Prot.
DT   18-MAR-2008, sequence version 2.
DT   07-APR-2021, entry version 154.
DE   RecName: Full=Centriolin;
DE   AltName: Full=Centrosomal protein 1;
DE   AltName: Full=Centrosomal protein of 110 kDa;
DE            Short=Cep110;
GN   Name=CNTRL; Synonyms=CEP1, CEP110;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, CHROMOSOMAL
RP   TRANSLOCATION WITH FGFR1, AND SUBCELLULAR LOCATION.
RX   PubMed=10688839;
RA   Guasch G., Mack G.J., Popovici C., Dastugue N., Birnbaum D., Rattner J.B.,
RA   Pebusque M.-J.;
RT   "FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12
RT   stem cell myeloproliferative disorder with t(8;9)(p12;q33).";
RL   Blood 95:1788-1796(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT ILE-56, SUBCELLULAR
RP   LOCATION, AND FUNCTION.
RX   PubMed=12732615; DOI=10.1083/jcb.200301105;
RA   Gromley A., Jurczyk A., Sillibourne J., Halilovic E., Mogensen M.,
RA   Groisman I., Blomberg M., Doxsey S.J.;
RT   "A novel human protein of the maternal centriole is required for the final
RT   stages of cytokinesis and entry into S phase.";
RL   J. Cell Biol. 161:535-545(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Liver;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1513 (ISOFORM 2).
RC   TISSUE=Lymph, and Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 434-1677 (ISOFORM 1).
RX   PubMed=16112646; DOI=10.1016/j.bbrc.2005.08.024;
RA   Guinn B.-A., Bland E.A., Lodi U., Liggins A.P., Tobal K., Petters S.,
RA   Wells J.W., Banham A.H., Mufti G.J.;
RT   "Humoral detection of leukaemia-associated antigens in presentation acute
RT   myeloid leukaemia.";
RL   Biochem. Biophys. Res. Commun. 335:1293-1304(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 527-2325 (ISOFORM 5).
RC   TISSUE=Spleen;
RX   PubMed=12693554; DOI=10.1093/dnares/10.1.49;
RA   Jikuya H., Takano J., Kikuno R., Hirosawa M., Nagase T., Nomura N.,
RA   Ohara O.;
RT   "Characterization of long cDNA clones from human adult spleen. II. The
RT   complete sequences of 81 cDNA clones.";
RL   DNA Res. 10:49-57(2003).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11956314;
RA   Ou Y.Y., Mack G.J., Zhang M., Rattner J.B.;
RT   "CEP110 and ninein are located in a specific domain of the centrosome
RT   associated with centrosome maturation.";
RL   J. Cell Sci. 115:1825-1835(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND SUBCELLULAR LOCATION [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH EXOC6 AND SNAPIN, AND SUBCELLULAR LOCATION.
RX   PubMed=16213214; DOI=10.1016/j.cell.2005.07.027;
RA   Gromley A., Yeaman C., Rosa J., Redick S., Chen C.-T., Mirabelle S.,
RA   Guha M., Sillibourne J., Doxsey S.J.;
RT   "Centriolin anchoring of exocyst and SNARE complexes at the midbody is
RT   required for secretory-vesicle-mediated abscission.";
RL   Cell 123:75-87(2005).
RN   [11]
RP   INTERACTION WITH HOOK2.
RX   PubMed=17140400; DOI=10.1111/j.1600-0854.2006.00511.x;
RA   Szebenyi G., Hall B., Yu R., Hashim A.I., Kraemer H.;
RT   "Hook2 localizes to the centrosome, binds directly to centriolin/CEP110 and
RT   contributes to centrosomal function.";
RL   Traffic 8:32-46(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-831 AND SER-1475, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Involved in cell cycle progression and cytokinesis. During
CC       the late steps of cytokinesis, anchors exocyst and SNARE complexes at
CC       the midbody, thereby allowing secretory vesicle-mediated abscission.
CC       {ECO:0000269|PubMed:12732615, ECO:0000269|PubMed:16213214}.
CC   -!- SUBUNIT: Interacts with HOOK2. Interacts with EXOC6 and SNAPIN.
CC       Associates with the exocyst complex. {ECO:0000269|PubMed:16213214,
CC       ECO:0000269|PubMed:17140400}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton, microtubule organizing
CC       center, centrosome {ECO:0000269|PubMed:10688839,
CC       ECO:0000269|PubMed:11956314, ECO:0000269|PubMed:12732615,
CC       ECO:0000269|PubMed:14654843}. Midbody, Midbody ring
CC       {ECO:0000269|PubMed:12732615, ECO:0000269|PubMed:16213214}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=Q7Z7A1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q7Z7A1-2; Sequence=VSP_032048;
CC       Name=3;
CC         IsoId=Q7Z7A1-3; Sequence=VSP_032047;
CC       Name=4;
CC         IsoId=Q7Z7A1-4; Sequence=VSP_032046, VSP_032050;
CC       Name=5;
CC         IsoId=Q7Z7A1-5; Sequence=VSP_032049;
CC   -!- TISSUE SPECIFICITY: Widely expressed with highest levels in testis and
CC       trachea. {ECO:0000269|PubMed:10688839}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CEP110 may be a cause
CC       of stem cell myeloproliferative disorder (MPD). Translocation
CC       t(8;9)(p12;q33) with FGFR1. MPD is characterized by myeloid
CC       hyperplasia, eosinophilia and T-cell or B-cell lymphoblastic lymphoma.
CC       In general it progresses to acute myeloid leukemia. The fusion protein
CC       CEP110-FGFR1 is found in the cytoplasm, exhibits constitutive kinase
CC       activity and may be responsible for the transforming activity.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH02932.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAH02932.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH89415.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF083322; AAC32373.1; -; mRNA.
DR   EMBL; AF513978; AAP43846.1; -; mRNA.
DR   EMBL; BX640927; CAE45965.1; -; mRNA.
DR   EMBL; AL137068; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC002932; AAH02932.1; ALT_SEQ; mRNA.
DR   EMBL; BC089415; AAH89415.1; ALT_SEQ; mRNA.
DR   EMBL; BC137286; AAI37287.1; -; mRNA.
DR   EMBL; AY651261; AAX35689.1; -; mRNA.
DR   EMBL; AK074079; BAB84905.1; -; mRNA.
DR   CCDS; CCDS35118.1; -. [Q7Z7A1-1]
DR   CCDS; CCDS83409.1; -. [Q7Z7A1-2]
DR   RefSeq; NP_001317691.1; NM_001330762.1. [Q7Z7A1-2]
DR   RefSeq; NP_008949.4; NM_007018.4. [Q7Z7A1-1]
DR   RefSeq; XP_005251736.1; XM_005251679.3.
DR   SMR; Q7Z7A1; -.
DR   BioGRID; 116248; 173.
DR   DIP; DIP-47280N; -.
DR   IntAct; Q7Z7A1; 187.
DR   MINT; Q7Z7A1; -.
DR   STRING; 9606.ENSP00000362962; -.
DR   CarbonylDB; Q7Z7A1; -.
DR   iPTMnet; Q7Z7A1; -.
DR   PhosphoSitePlus; Q7Z7A1; -.
DR   BioMuta; CNTRL; -.
DR   DMDM; 172045911; -.
DR   EPD; Q7Z7A1; -.
DR   jPOST; Q7Z7A1; -.
DR   MassIVE; Q7Z7A1; -.
DR   MaxQB; Q7Z7A1; -.
DR   PaxDb; Q7Z7A1; -.
DR   PeptideAtlas; Q7Z7A1; -.
DR   PRIDE; Q7Z7A1; -.
DR   ProteomicsDB; 69493; -. [Q7Z7A1-1]
DR   ProteomicsDB; 69494; -. [Q7Z7A1-2]
DR   ProteomicsDB; 69495; -. [Q7Z7A1-3]
DR   ProteomicsDB; 69496; -. [Q7Z7A1-4]
DR   ProteomicsDB; 69497; -. [Q7Z7A1-5]
DR   Antibodypedia; 30137; 30 antibodies.
DR   Ensembl; ENST00000373850; ENSP00000362956; ENSG00000119397. [Q7Z7A1-2]
DR   Ensembl; ENST00000373855; ENSP00000362962; ENSG00000119397. [Q7Z7A1-1]
DR   GeneID; 11064; -.
DR   KEGG; hsa:11064; -.
DR   UCSC; uc004bkx.1; human. [Q7Z7A1-1]
DR   CTD; 11064; -.
DR   DisGeNET; 11064; -.
DR   GeneCards; CNTRL; -.
DR   HGNC; HGNC:1858; CNTRL.
DR   HPA; ENSG00000119397; Low tissue specificity.
DR   MIM; 605496; gene.
DR   neXtProt; NX_Q7Z7A1; -.
DR   OpenTargets; ENSG00000119397; -.
DR   PharmGKB; PA26414; -.
DR   VEuPathDB; HostDB:ENSG00000119397.16; -.
DR   eggNOG; KOG0531; Eukaryota.
DR   GeneTree; ENSGT00940000155434; -.
DR   HOGENOM; CLU_231608_0_0_1; -.
DR   InParanoid; Q7Z7A1; -.
DR   OMA; QHEYLEL; -.
DR   OrthoDB; 79816at2759; -.
DR   PhylomeDB; Q7Z7A1; -.
DR   TreeFam; TF101135; -.
DR   PathwayCommons; Q7Z7A1; -.
DR   Reactome; R-HSA-1839117; Signaling by cytosolic FGFR1 fusion mutants. [Q7Z7A1-3]
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5655302; Signaling by FGFR1 in disease. [Q7Z7A1-3]
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   SIGNOR; Q7Z7A1; -.
DR   BioGRID-ORCS; 11064; 12 hits in 1001 CRISPR screens.
DR   ChiTaRS; CNTRL; human.
DR   GeneWiki; CNTRL; -.
DR   GenomeRNAi; 11064; -.
DR   Pharos; Q7Z7A1; Tbio.
DR   PRO; PR:Q7Z7A1; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q7Z7A1; protein.
DR   Bgee; ENSG00000119397; Expressed in testis and 214 other tissues.
DR   ExpressionAtlas; Q7Z7A1; baseline and differential.
DR   Genevisible; Q7Z7A1; HS.
DR   GO; GO:0120103; C:centriolar subdistal appendage; IDA:GO_Central.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0090543; C:Flemming body; IEA:UniProtKB-SubCell.
DR   GO; GO:0090619; C:meiotic spindle pole; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005815; C:microtubule organizing center; IBA:GO_Central.
DR   GO; GO:0097431; C:mitotic spindle pole; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IEA:InterPro.
DR   GO; GO:0035904; P:aorta development; IEA:Ensembl.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0060976; P:coronary vasculature development; IEA:Ensembl.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0001822; P:kidney development; IEA:Ensembl.
DR   GO; GO:0051493; P:regulation of cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0003281; P:ventricular septum development; IEA:Ensembl.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR028640; CEP110.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   PANTHER; PTHR34491:SF2; PTHR34491:SF2; 1.
DR   SMART; SM00369; LRR_TYP; 3.
DR   PROSITE; PS51450; LRR; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Cell cycle; Cell division; Chromosomal rearrangement;
KW   Coiled coil; Cytoplasm; Cytoskeleton; Leucine-rich repeat; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN           1..2325
FT                   /note="Centriolin"
FT                   /id="PRO_0000323675"
FT   REPEAT          126..147
FT                   /note="LRR 1"
FT   REPEAT          148..169
FT                   /note="LRR 2"
FT   REPEAT          170..191
FT                   /note="LRR 3"
FT   REPEAT          194..215
FT                   /note="LRR 4"
FT   DOMAIN          228..266
FT                   /note="LRRCT"
FT   REGION          1948..2118
FT                   /note="Required for centrosome localization"
FT   REGION          1985..2325
FT                   /note="Sufficient for interaction with HOOK2"
FT                   /evidence="ECO:0000269|PubMed:17140400"
FT   COILED          267..343
FT                   /evidence="ECO:0000255"
FT   COILED          435..799
FT                   /evidence="ECO:0000255"
FT   COILED          851..1101
FT                   /evidence="ECO:0000255"
FT   COILED          1317..2255
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        956..959
FT                   /note="Poly-Lys"
FT   COMPBIAS        1147..1150
FT                   /note="Poly-Pro"
FT   COMPBIAS        1236..1307
FT                   /note="Pro-rich"
FT   SITE            2139..2140
FT                   /note="Breakpoint for translocation to form CEP110-FGFR1"
FT   MOD_RES         831
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         1475
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..1818
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_032046"
FT   VAR_SEQ         1..1331
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10688839"
FT                   /id="VSP_032047"
FT   VAR_SEQ         1..552
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_032048"
FT   VAR_SEQ         1291..1296
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:12693554"
FT                   /id="VSP_032049"
FT   VAR_SEQ         1962..1986
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_032050"
FT   VARIANT         56
FT                   /note="V -> I (in dbSNP:rs10818503)"
FT                   /evidence="ECO:0000269|PubMed:12732615"
FT                   /id="VAR_039559"
FT   VARIANT         216
FT                   /note="P -> L (in dbSNP:rs10818504)"
FT                   /id="VAR_039560"
FT   VARIANT         889
FT                   /note="A -> T (in dbSNP:rs17292952)"
FT                   /id="VAR_039561"
FT   VARIANT         1146
FT                   /note="M -> V (in dbSNP:rs35342437)"
FT                   /id="VAR_061622"
FT   CONFLICT        1389
FT                   /note="Q -> R (in Ref. 1; AAC32373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1699
FT                   /note="K -> Q (in Ref. 1; AAC32373)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1828
FT                   /note="E -> D (in Ref. 1; AAC32373)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   2325 AA;  268886 MW;  93DD4CA08B5BD4AF CRC64;
     MKKGSQQKIF SKAKIPSSSH SPIPSSMSNM RSRSLSPLIG SETLPFHSGG QWCEQVEIAD
     ENNMLLDYQD HKGADSHAGV RYITEALIKK LTKQDNLALI KSLNLSLSKD GGKKFKYIEN
     LEKCVKLEVL NLSYNLIGKI EKLDKLLKLR ELNLSYNKIS KIEGIENMCN LQKLNLAGNE
     IEHIPVWLGK KLKSLRVLNL KGNKISSLQD ISKLKPLQDL ISLILVENPV VTLPHYLQFT
     IFHLRSLESL EGQPVTTQDR QEAFERFSLE EVERLERDLE KKMIETEELK SKQTRFLEEI
     KNQDKLNKSL KEEAMLQKQS CEELKSDLNT KNELLKQKTI ELTRACQKQY ELEQELAFYK
     IDAKFEPLNY YPSEYAEIDK APDESPYIGK SRYKRNMFAT ESYIIDSAQA VQIKKMEPDE
     QLRNDHMNLR GHTPLDTQLE DKEKKISAAQ TRLSELHDEI EKAEQQILRA TEEFKQLEEA
     IQLKKISEAG KDLLYKQLSG RLQLVNKLRQ EALDLELQME KQKQEIAGKQ KEIKDLQIAI
     DSLDSKDPKH SHMKAQKSGK EQQLDIMNKQ YQQLESRLDE ILSRIAKETE EIKDLEEQLT
     EGQIAANEAL KKDLEGVISG LQEYLGTIKG QATQAQNECR KLRDEKETLL QRLTEVEQER
     DQLEIVAMDA ENMRKELAEL ESALQEQHEV NASLQQTQGD LSAYEAELEA RLNLRDAEAN
     QLKEELEKVT RLTQLEQSAL QAELEKERQA LKNALGKAQF SEEKEQENSE LHAKLKHLQD
     DNNLLKQQLK DFQNHLNHVV DGLVRPEEVA ARVDELRRKL KLGTGEMNIH SPSDVLGKSL
     ADLQKQFSEI LARSKWERDE AQVRERKLQE EMALQQEKLA TGQEEFRQAC ERALEARMNF
     DKRQHEARIQ QMENEIHYLQ ENLKSMEEIQ GLTDLQLQEA DEEKERILAQ LRELEKKKKL
     EDAKSQEQVF GLDKELKKLK KAVATSDKLA TAELTIAKDQ LKSLHGTVMK INQERAEELQ
     EAERFSRKAA QAARDLTRAE AEIELLQNLL RQKGEQFRLE MEKTGVGTGA NSQVLEIEKL
     NETMERQRTE IARLQNVLDL TGSDNKGGFE NVLEEIAELR REVSYQNDYI SSMADPFKRR
     GYWYFMPPPP SSKVSSHSSQ ATKDSGVGLK YSASTPVRKP RPGQQDGKEG SQPPPASGYW
     VYSPIRSGLH KLFPSRDADS GGDSQEESEL DDQEEPPFVP PPGYMMYTVL PDGSPVPQGM
     ALYAPPPPLP NNSRPLTPGT VVYGPPPAGA PMVYGPPPPN FSIPFIPMGV LHCNVPEHHN
     LENEVSRLED IMQHLKSKKR EERWMRASKR QSEKEMEELH HNIDDLLQEK KSLECEVEEL
     HRTVQKRQQQ KDFIDGNVES LMTELEIEKS LKHHEDIVDE IECIEKTLLK RRSELREADR
     LLAEAESELS CTKEKTKNAV EKFTDAKRSL LQTESDAEEL ERRAQETAVN LVKADQQLRS
     LQADAKDLEQ HKIKQEEILK EINKIVAAKD SDFQCLSKKK EKLTEELQKL QKDIEMAERN
     EDHHLQVLKE SEVLLQAKRA ELEKLKSQVT SQQQEMAVLD RQLGHKKEEL HLLQGSMVQA
     KADLQEALRL GETEVTEKCN HIREVKSLLE ELSFQKGELN VQISERKTQL TLIKQEIEKE
     EENLQVVLRQ MSKHKTELKN ILDMLQLENH ELQGLKLQHD QRVSELEKTQ VAVLEEKLEL
     ENLQQISQQQ KGEIEWQKQL LERDKREIER MTAESRALQS CVECLSKEKE DLQEKCDIWE
     KKLAQTKRVL AAAEENSKME QSNLEKLELN VRKLQQELDQ LNRDKLSLHN DISAMQQQLQ
     EKREAVNSLQ EELANVQDHL NLAKQDLLHT TKHQDVLLSE QTRLQKDISE WANRFEDCQK
     EEETKQQQLQ VLQNEIEENK LKLVQQEMMF QRLQKERESE ESKLETSKVT LKEQQHQLEK
     ELTDQKSKLD QVLSKVLAAE ERVRTLQEEE RWCESLEKTL SQTKRQLSER EQQLVEKSGE
     LLALQKEADS MRADFSLLRN QFLTERKKAE KQVASLKEAL KIQRSQLEKN LLEQKQENSC
     IQKEMATIEL VAQDNHERAR RLMKELNQMQ YEYTELKKQM ANQKDLERRQ MEISDAMRTL
     KSEVKDEIRT SLKNLNQFLP ELPADLEAIL ERNENLEGEL ESLKENLPFT MNEGPFEEKL
     NFSQVHIMDE HWRGEALREK LRHREDRLKA QLRHCMSKQA EVLIKGKRQT EGTLHSLRRQ
     VDALGELVTS TSADSASSPS LSQLESSLTE DSQLGQNQEK NASAR
//
